We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

78 hedge funds and large institutions have $63.7M invested in VanEck Biotech ETF in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less call options, than puts

Call options by funds: $2.85M | Put options by funds: $2.87M

0.93% less ownership

Funds ownership: 20.54% → 19.61% (-0.93%)

7% less funds holding

Funds holding: 84 → 78 (-6)

18% less capital invested

Capital invested by funds: $78M → $63.7M (-$14.3M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

69% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 26

Holders
78
Holders Change
-6
Holders Change %
-7.14%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
26
Closed
13
Calls
$2.85M
Puts
$2.87M
Net Calls
-$24K
Net Calls Change
-$9.18M

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$2.84M
2
Jane Street
Jane Street
New York
+$1.29M
3
TRCT
Tower Research Capital (TRC)
New York
+$340K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$336K
5
MJRIC
Mogy Joel R Investment Counsel
California
+$155K

Top Sellers

Rank Fund Capital Flow
1
TIA
Traphagen Investment Advisors
New Jersey
-$6.34M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.25M
3
AFG
Albion Financial Group
Utah
-$1.24M
4
Simplex Trading
Simplex Trading
Illinois
-$823K
5
UBS Group
UBS Group
Switzerland
-$640K
Name Holding Trade Value Shares
Change 		Change in
Stake
QAM
76
QCI Asset Management
New York
$3K – – –
AIP
77
Ameritas Investment Partners
Nebraska
$2K – – –
VFA
78
Valeo Financial Advisors
Indiana
$1K +$1.24K +10 New
TIA
79
Traphagen Investment Advisors
New Jersey
– -$6.34M -49,188 Closed
AFG
80
Albion Financial Group
Utah
– -$1.24M -9,597 Closed
AB
81
Atlas Brown
Kentucky
– -$361K -2,796 Closed
MML Investors Services
82
MML Investors Services
Massachusetts
– -$259K -2,011 Closed
TCM
83
Tufton Capital Management
Maryland
– -$212K -1,650 Closed
B
84
Bailard
California
– -$210K -1,626 Closed
IWC
85
Integrated Wealth Concepts
Massachusetts
– -$208K -1,617 Closed
BRWM
86
B. Riley Wealth Management
Tennessee
– -$110 -852 Closed
MWM
87
Meridian Wealth Management
Kentucky
– -$257 -200 Closed
Deutsche Bank
88
Deutsche Bank
Germany
– -$19K -150 Closed
WAP
89
Wealthcare Advisory Partners
Pennsylvania
– -$12K -94 Closed
GRP
90
Global Retirement Partners
California
– -$6K -50 Closed
1 2 3
4

BBH Hedge Fund Activity: Q3 2019 in Review

78 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2019, worth a combined $63.7M — down 18% from $78M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 8 opened new positions — a net loss of 5 holders — while 26 trimmed existing stakes and 8 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $2.84M. The largest seller was Traphagen Investment Advisors, exiting entirely with an estimated $6.34M sold.

  • 78 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2019, down from 84 in Q2 2019.
  • Funds reported $63.7M of VanEck Biotech ETF stock for Q3 2019, down 18% quarter-over-quarter.
  • 8 funds opened new VanEck Biotech ETF positions in Q3 2019 and 13 closed out, a net change of -5 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2019 was Virtu Financial, an estimated $2.84M added.
  • The largest VanEck Biotech ETF seller in Q3 2019 was Traphagen Investment Advisors, an estimated $6.34M sold.

Based on aggregated 13F filings for Q3 2019.